Clinical Kidney Journal

Papers
(The H4-Index of Clinical Kidney Journal is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Prolonged normothermic perfusion: a promising approach to kidney transplantation158
A puzzling renal Fanconi syndrome95
Donor-derived membranous nephropathy80
Correction to: Accelerated versus watchful waiting strategy of kidney replacement therapy for acute kidney injury: a systematic review and meta-analysis of randomized clinical trials71
But how green is it actually? Calculating the environmental footprint of kidney care environmental optimizations within haemodialysis64
Cerebral blood flow following successful living kidney transplantation: the VINTAGE study55
Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study52
Clinically meaningful eGFR slope as a surrogate endpoint differs across CKD stages and slope evaluation periods: the CKD-JAC study52
Non-invasive assessment of IgA nephropathy severity with [18F]AlF-NOTA-FAPI-04 PET/CT imaging49
Robot-assisted kidney transplantation: an update48
Plant-based diets for CKD patients: fascinating, trendy, but feasible? A green nephrology perspective45
Efficacy and safety of telitacicept, a BLyS/APRIL dual inhibitor, in the treatment of IgA nephropathy: a retrospective case–control study44
Obinutuzumab treatment for membranous nephropathy: effectiveness and safety concerns during the COVID-19 pandemic43
Standardization of serum creatinine is essential for accurate use of unbiased estimated GFR equations: evidence from three cohorts matched on renal function41
Impact of the COVID pandemic on vascular access creation for haemodialysis in 16 Spanish haemodialysis centres40
Risk factors for steroid-induced osteonecrosis of the femoral head in children with immune kidney disease40
Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study39
Interaction of general obesity and abdominal obesity with frailty in patients with chronic kidney disease: a nationally representative analysis36
Biomarkers in clinical epidemiology studies36
Toward acid- and heparin-free dialysis: the regional anticoagulation approach36
Informal caregiver burden in dialysis care and how it relates to patients’ health-related quality of life and symptoms36
Differentiating primary and secondary FSGS using non-invasive urine biomarkers35
Causal relationships between immune cell phenotypes and primary glomerular diseases: genetic evidence from bidirectional Mendelian randomization study35
Circulating miR-129-3p in combination with clinical factors predicts vascular calcification in hemodialysis patients35
Bilateral nephrectomy in autosomal dominant polycystic kidney disease patients before or after renal transplantation: data from a retrospective cohort study34
Correction to: Recognition of intraglomerular histological features with deep learning in protocol transplant biopsies and their association with kidney function and prognosis33
Recent advances in pathogenetic concepts and disease modeling of IgA nephropathy33
Association between frailty and bone health in early-stage chronic kidney disease: a study from the population-based CARTaGENE cohort33
Ten tips on how to manage kidney health in migrants and refugees33
Can exercise improve outcomes for frail haemodialysis patients?33
Probability of chronic kidney disease and associated risk factors in Chinese adults: a cross-sectional study of 9 million Chinese adults in the Meinian Onehealth screening survey31
Performance of the race-free CKD-EPI creatinine-based eGFR equation in a Danish cohort with measured GFR31
The spectrum of diseases, genetic landscape and new mutation sites of hereditary cystic kidney disease31
0.12937593460083